S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer
NCT01175460
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Cancer
Interventions
DRUG:
S-1, Nedaplatin
Sponsor
Zhejiang Cancer Hospital